Level Four Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,904
Closed -$786K – 652
2021
Q3
$786K Sell
1,904
-272
-13% -$113K 0.08% 213
2021
Q2
$805K Buy
2,176
+128
+6% +$42.7K 0.06% 302
2021
Q1
$594K Buy
+2,048
New +$569K 0.05% 354

Other funds holding CRL

Level Four Advisory Services's CRL Position: Q4 2021 in Review

Level Four Advisory Services sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 1,904 shares — an estimated $786K sold.

Level Four Advisory Services first reported a position in CRL in Q1 2021 and held it in 3 quarters. The position peaked at $805K in Q2 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Level Four Advisory Services reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Level Four Advisory Services sold 1,904 Charles River Laboratories shares in Q4 2021, an estimated $786K.
  • Level Four Advisory Services first reported a position in Charles River Laboratories in Q1 2021 and held it in 3 quarters.
  • Level Four Advisory Services's Charles River Laboratories position peaked at $805K in Q2 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Level Four Advisory Services's 13F filing for Q4 2021, filed 11 Feb 2022.